References

• van der Meere, Sergeant J. Focused attention in pervasively hyperactive children. J Abnorm Child Psychol 1988;16:627–639.
   Web of Science ®Google Scholar
• Mostofsky SH, Lasker AG, Cutting LE, Denckla MB, Zee DS. Oculomotor abnormalities in attention deficit hyperactivity disorder: a preliminary study. Neurology 2001;57:423–430.
   PubMed Web of Science ®Google Scholar
• Shue KL, Douglas VI. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn 1992;20:104–124.
   PubMed Web of Science ®Google Scholar
• Oosterlaan J, Logan GD, Sergeant JA. Response inhibition in AD/HD, CD, comorbid AD/HD + CD, anxious, and control children: a meta-analysis of studies with the stop task. J Child Psychol Psychiatry 1998;39: 411–425.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, Greene R. Attention-deficit hyperactivity disorder. In: Martin A, Scahill L, Charney DS, Leckman JF, editors. Pediatric Psychopharmacology. New York: Oxford University Press; 2003. 447–465.
   Google Scholar
• Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kübber S, Linder M, et al. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) 2006;185:315–326.
   Google Scholar
• Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry 2001;40:180–187.
   PubMed Web of Science ®Google Scholar
• Ziemann U. TMS and drugs. Clin Neurophysiol 2004; 115:1717–1729.
   PubMed Web of Science ®Google Scholar
• Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps TD, Wassermann EM. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 2006;31:442–449.
   PubMed Web of Science ®Google Scholar
• Richter MM, Ehlis AC, Jacob CP, Fallgatter AJ. Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD). Neurosci Lett 2007;419:137–1341.
   Web of Science ®Google Scholar
• Rossini PM, Rossi S. Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential. Neurology 2007;68:484–488.
   PubMed Web of Science ®Google Scholar
• Chen R, Cros D, Curra A, Di Lazzaro V, Lefaucheur JP, et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2008;119:504–532.
   PubMed Web of Science ®Google Scholar
• Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 2000; 284:121–125.
   PubMed Web of Science ®Google Scholar
• Buchmann J, Wolters A, Haessler F, Bohne S, Nordbeck R, Kunesch E. Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD). Clin Neurophysiol 2003;114:2036–2042.
   Web of Science ®Google Scholar
• Garvey MA, Barker CA, Bartko JJ, Denckla MB, Wassermann EM, Castellanos FX, Dell ML, Ziemann U. The ipsilateral silent period in boys with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2005;116:1889–1896.
   PubMed Web of Science ®Google Scholar
• Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Benecke R, Haessler F, Wolters A. Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate. Biol Psychiatry 2007;62:963–969.
   Web of Science ®Google Scholar
• Hoeppner J, Neumeyer M, Wandschneider R, Herpertz SC, Gierow W, Haessler F, et al. Intracortical motor inhibition and facilitation in adults with attention deficit/hyperactivity disorder. J Neural Transm 2008;115:1701–1707
   Web of Science ®Google Scholar
• Moll GH, Heinrich H, Rothenberger A. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr Scand 2003;107:69–72.
   Web of Science ®Google Scholar
• Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Wittstock M, Benecke R, Haessler F, Wolters A. Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH). Neurosci Lett 2006;405:14–18.
   Web of Science ®Google Scholar
• Uclés P, Lorente S. Electrophysiologic measures of delayed maturation in attention-deficit hyperactivity disorder. J Child Neurol 1996;11:155–156.
   Web of Science ®Google Scholar
• Uclés P, Serrano JL, Rosa F. Central conduction time of magnetic brain stimulation in attention-deficit hyperactivity disorder. J Child Neurol 2000;15:723–728.
   PubMed Web of Science ®Google Scholar
• Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996;496:873–881.
   PubMed Web of Science ®Google Scholar
• Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65–94.
   PubMed Web of Science ®Google Scholar
• Rothwell JC, Thompson PD, Day BL, Boyd S, Marsden CD. Stimulation of the human motor cortex through the scalp. Exp Physiol 1991;76:159–200.
   PubMed Web of Science ®Google Scholar
• Moll GH, Heinrich H, Wischer S, Tergau F, Paulus W, Rothenberger A. Motor system excitability in healthy children: developmental aspects from transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol (Suppl) 1999;51:243–249.
   Google Scholar
• Awenowicz PW, Porter LL. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. J Neurophysiol 2002;88:3439–3451.
   Web of Science ®Google Scholar
• Winsberg BG, Javitt DC, Silipo GS, Doneshka P. Mismatch negativity in hyperactive children: effects of methylphenidate. Psychopharmacol Bull 1993; 29: 229–233.
   PubMed Web of Science ®Google Scholar
• Ozdag MF, Yorbik O, Ulas UH, Hamamcioglu K, Vural O. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder. Int J Pediatr Otorhinolaryngol 2004;68:1267–1272.
   PubMed Web of Science ®Google Scholar
• Yorbik O, Ozdag MF, Kirmizigul P, Ulas UH, Hamamcioglu K, Vural O. Auditory event related potentials in boys with attention deficit hyperactivity disorder. Turkish Journal of Child and Adolescent Mental Health 2004; 11:44–49.
   Google Scholar
• Yorbik O, Ozdag MF, Olgun A, Senol MG, Bek S, Akman S. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:662–667.
   Web of Science ®Google Scholar
• Young ES, Perros P, Price GW, Sadler T. Acute challenge ERP as a prognostic of stimulant therapy outcome in attention-deficit hyperactivity disorder. Biol Psychiatry 1995; 37: 25–33.
   PubMed Web of Science ®Google Scholar
• Seifert J, Scheuerpflug P, Zillessen KE, Fallgatter A, Warnke A. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. J Neural Transm 2003; 110: 821–829.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; Washington, 1994.
   Google Scholar
• Ercan ES, Amado S, Somer O, Çikoglu S. Development of A Test Battery for the Assessment of Attention Deficit Hyperactivity Disorder. Journal of Child and Adolescent Mental Health (Turkish) 2001;8:132–144
   Google Scholar
• Terao Y, Ugawa Y. Basic mechanisms of TMS. J Clin Neurophysiol 2002;19: 322–343.
   PubMed Web of Science ®Google Scholar
• Arnsten AF. Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology 2006;31:2376–2383.
   PubMed Web of Science ®Google Scholar
• Gaspar P, Berger B, Febvret A, Vigny A, Henry JP. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 1989;279:249–271.
   PubMed Web of Science ®Google Scholar
• Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 1991;30:365–374
   Web of Science ®Google Scholar
• Berger B, Verney C, Alvarez C, Vigny A, Helle KB. New dopaminergic terminal fields in the motor, visual (area 18b) and retrosplenial cortex in the young and adult rat. Immunocytochemical and catecholamine histochemical analyses. Neuroscience 1985;15:983–998.
   Web of Science ®Google Scholar
• Reid MS, Hsu K Jr, Berger SP. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 1997;27:95–105.
   PubMed Web of Science ®Google Scholar
• Zheng P, Zhang XX, Bunney BS, Shi WX. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 1999;91:527–535.
   Web of Science ®Google Scholar
• Garvey MA, Mall V. Transcranial magnetic stimulation in children. Clin Neurophysiol 2008;119:973–984.
   PubMed Web of Science ®Google Scholar
• Mavroudakis N, Caroyer JM, Brunko E, Zegers de Beyl D. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 1994;93:428–433.
   Google Scholar
• Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996;40:367–378.
   PubMed Web of Science ®Google Scholar
• Chen R, Samii A, Caños M, Wassermann EM, Hallett M. Effects of phenytoin on cortical excitability in humans. Neurology 1997;49:881–883.
   PubMed Web of Science ®Google Scholar
• Boroojerdi B, Battaglia F, Muellbacher W, Cohen LG. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 2001;112:931–937.
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Pilato F, Zito G, et al. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol 2003;547:485–496.
   PubMed Web of Science ®Google Scholar
• Scalise A, Desiato MT, Gigli GL, Romigi A, Tombini M, Marciani MG, et al. Increasing cortical excitability: a possible explanation for the proconvulsant role of sleep deprivation. Sleep 2006;29:1595–1598.
   Web of Science ®Google Scholar
• Priori A, Berardelli A, Mercuri B, Inghilleri M, Manfredi M. The effect of hyperventilation on motor cortical inhibition in humans: a study of the electromyographic silent period evoked by transcranial brain stimulation. Electroencephalogr Clin Neurophysiol 1995;97:69–72.
   Google Scholar
• Taylor JL, Gandevia SC. Transcranial magnetic stimulation and human muscle fatigue. Muscle Nerve 2001; 24:18–29.
   PubMed Web of Science ®Google Scholar
• Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117:317–323.
   Web of Science ®Google Scholar
• Torres AR, Whitney J, Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008;12:217–233.
   PubMed Web of Science ®Google Scholar